In Vitro Diagnostics Market

In Vitro Diagnostics Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023

Report Code: MD 3609 Mar, 2018, by marketsandmarkets.com

[405 Pages Report] MarketsandMarkets forecasts the global in vitro diagnostics market to grow from USD 87.93 billion in 2018 to USD 68.12 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. The major factors that are expected to be driving the in vitro diagnostics market are the geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments and automation in laboratories. In addition, increasing adoption of point-of-care testing, and growing awareness on personalized medicine is expected to drive the growth of the in vitro diagnostics market during the forecast period. The objective of the report is to define, describe, and forecast the in vitro diagnostics market size based on product & service, technology, application, end user, and regions.

In Vitro Diagnostics/ IVD Market, By Region, 2023 (USD Billion)

By product and services, reagents & kits segment is expected to grow at the highest growth rate during the forecast period

Among the product and service, segment, the reagents & kits segment is expected to grow at the highest CAGR during the forecast period. The factors attributing to the high growth of this segment include the increased accessibility and demand for reagents and the rising number of IVD tests conducted across the globe.

By application, the infectious diseases segment is expected to account for the largest share of the in vitro diagnostics market

On the basis application, the in vitro diagnostics market is segmented into diabetes, infectious diseases, oncology, cardiology, nephrology, autoimmune diseases, drug testing/pharmacogenomics, HIV/AIDS, and other applications. The infectious diseases segment is expected to account for the largest share of the in vitro diagnostics market during the forecast period. The large share of this segment can be attributed to the rising prevalence of infectious diseases as well as multi-drug-resistant infectious diseases across the globe and the growing need for effective diagnostic tools for these diseases.

By technology, the molecular diagnostics segment is expected to record the highest CAGR during the forecast period

The molecular diagnostics segment is expected to witness a faster growth rate in this market due to factors such as, the rising prevalence of infectious diseases, cancer, and various genetic disorders; growing demand for blood screening; and increasing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing.

By end user, the hospitals segment is expected to account for the largest share of the in vitro diagnostics market

On the basis of end user, the in vitro diagnostic market is segmented into laboratories, hospitals, academic institutes, point-of-care testing, patient self-testing, and other end users. The hospitals segment is expected to account for the largest share of the in vitro diagnostics market during the forecast period. The large share of this segment can be attributed to the large volume of diagnostic tests carried out in hospitals.

In Vitro Diagnostics/ IVD Market, By Region, 2023 (USD Billion)

North America to account for the largest market size during the forecast period.

North America is expected to hold the largest market size in the global in vitro diagnostics market during the forecast period, followed by the European region. Availability of government funds, growing use of molecular diagnostics in genetic disorders and cancer screening, and the presence of key players in the region are responsible for the large share of the North American in vitro diagnostics market. 

Market Dynamics

Driver: Increasing adoption of fully automated instruments and automation in laboratories

The market is gaining traction due to the increasing adoption of fully automated instruments in diagnostic laboratories. As compared to non-automated instruments, fully automated instruments are more scalable, high-performance, help in decreasing hands-on time, eliminate batch testing, and deliver faster results to physicians. Due to these advantages, market players are increasingly focusing on developing automated instruments. Moreover, automation in laboratories enables, expedites, and increases the efficiency and effectiveness of diagnostic tests in laboratories. Total lab automation system is capable of handling all aspects of the testing process, from the loading of specimen tubes to generating results for all major lab disciplines

Restraint: Unfavorable reimbursement scenario

Inadequate reimbursement is a major factor restraining the growth of the IVD market. Medicare revised its reimbursement mechanism for some IVD tests, including molecular tests, in 2012. Some of these molecular pathology tests do not have their own Healthcare Common Procedure Coding System (HCPCS) codes and are instead billed using unlisted codes. In such cases, Medicare Administrative Contractors (MACs) establish a payment amount for their local jurisdictions. According to CMS, approximately 75% of tests showed reductions in reimbursement rate from January 2017. Some of these tests include molecular tests, targeted NGS analysis panels of five to 50 genes, and cancer tests. These developments are expected to adversely affect the US molecular and genetic testing market, which will hinder the growth of the IVD market.

Opportunity: Development of condition-specific markers and tests

Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases. In the diagnosis process, markers can determine staging, grading, and selection of the initial therapy. During treatments, they can be used to monitor therapy, select additional therapies, or monitor recurrent diseases. Technological advancements in genomics, proteomics, and molecular pathology have helped introduce new biomarkers with potential clinical value. The integration of biomarkers and the availability of biomolecular tools are expected to help in the development of a new range of condition-specific tests, thus creating new opportunities for the IVD market.

Challenge: Operational barriers faced in conducting diagnostic tests

Clinical laboratories across major markets are still evolving; technicians face operational challenges in ensuring effective sample procurement, storage, and transportation, especially while adopting novel technologies such as NGS and lab-on-chip PCR devices. Laboratory space also needs to be reconfigured to meet the requirements of conducting specific molecular diagnostic tests used for pathogen detection, as a means of avoiding cross-contamination and ensuring efficient time management. This results in considerable cost escalation to maintain and operate advanced molecular diagnostic instruments, particularly those capable of handling a single sample type. Furthermore, due to the rapid mutation of microbes and the increasing outbreak of epidemics, clinical laboratories need to adopt innovative technologies capable of rapid sample diagnosis. However, the dearth of skilled and technically knowledgeable laboratory technicians to operate advanced molecular diagnostic products has hindered their overall adoption, particularly among emerging markets.

In Vitro Diagnostics/ IVD Market, By Region, 2023 (USD Billion)

Scope of the Report

Report Metric

Details

Market size available for years

2016–2023

Base year considered

2017

Forecast period

2016–2023

Forecast units

Million (USD)

Segments covered

By product & service, technology, application, end user, and region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMιrieux (France), Diasorin (Italy), Ortho-Clinical Diagnostics (US), and Qiagen (Germany).

The research report categorizes the in vitro diagnostics market to forecast the revenues and analyze the trends in each of the following sub-segments:

Global In Vitro Diagnostics Market, by Product & Service

  • Reagents & Kits
  • Instruments
    • Fully-automated Instruments
    • Semi-automated Instruments
    • Others
  • Data Management Software
  • Services

Global In Vitro Diagnostics Market, by Technology

  • Immunochemistry/Immunoassay
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence Immunoassay (FIA)
      • Colorimetric Immunoassay (CI)
    • Radioimmunoassays (RIA)
    • Rapid Tests
    • Western Blot
    • ELISPOT
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Electrolyte Panel
    • Liver Panel
    • Lipid Profile
    • Renal Profile
    • Thyroid Function Panel
    • Specialty Chemicals
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization (In-situ Hybridization & FISH)
    • DNA Sequencing & NGS
    • Microarray
    • Others
  • Microbiology
  • Hematology
  • Coagulation & Hemostasis
  • Urinalysis
  • Others

Global In Vitro Diagnostics Market, by Application

  • Diabetes
  • Infectious Diseases
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing/Pharmacogenomics
  • HIV/AIDS
  • Others  

Global In Vitro Diagnostics Market, by End User

  • Laboratories
    • Large/Reference Laboratories
    • Medium-sized Laboratories
    • Small Laboratories
  • Hospitals
  • Academics
  • Point-Of-Care Testing
  • Patient Self-Testing
  • Others

Global In Vitro Diagnostics Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Russia
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Australia
    • Singapore
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
  • Middle East & Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

Key Market Players

Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMιrieux (France), Diasorin (Italy), Ortho-Clinical Diagnostics (US), and Qiagen (Germany).

Roche Diagnostics Limited (Switzerland) dominated the global in vitro diagnostics market in 2017. The company’s leading position in the IVD market is attributed to its wide product portfolio, which includes clinical chemistry, immunochemistry, molecular diagnostics, and tissue diagnostics instruments, reagents, and kits. Under its flagship brand, Cobas, the company offers a variety of IVD instruments, reagents, and kits that are widely used by end users across the globe. The company also has a wide geographic presence, spanning North America, Europe, the Middle East and Africa, and Asia, which enables it to cater to customers across the globe. The company mainly focuses on product launches and strategic partnerships and collaborations to maintain its leadership position in the market.

Recent Developments

  • In January 2018, Roche Diagnostics (Switzerland) and GE Healthcare (US) entered into collaboration to jointly develop and co-market digital clinical decision support solutions. The two companies aim to develop an industry-first digital platform, using advanced analytics to provide workflow solutions and apps that support clinical decisions
  • In January 2018, Abbott Laboratories (US) launched FreeStyle Libre System, new continuous glucose monitoring (CGM) system.
  • In January 2017, Roche Diagnostics (Switzerland) launched cobas m 511 integrated hematology analyzer.
  • In November 2016, Danaher Corporation (US) has acquired Cepheid Inc. (US) to expand its diagnostics business with Cepheid’s molecular diagnostic systems and tests. In addition, the acquisition helps Danaher to strengthen its business presence in the rapidly growing molecular diagnostics market.
  • In June 2016 Danaher Corporation (US) and Advanced Cell Diagnostics, Inc. (US) entered into an agreement to develop and commercialize innovative tissue diagnostic instruments.

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends in the in vitro diagnostics market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading players operating in this market?
  • What are the opportunities for new market entrants?

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
    4.1 In Vitro Diagnostics (IVD) Market Overview
    4.2 Asia Pacific: Market, By Product & Service
    4.3 Geographic Snapshot of the Market
    4.4 Geographic Mix: In Vitro Diagnostics Market
    4.5 Market: Developing vs Developed Markets

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Geriatric Population and Subsequent Growth in the Prevalence of Chronic and Infectious Diseases
                    5.2.1.2 Increasing Adoption of Fully Automated Instruments and Automation in Laboratories
                    5.2.1.3 Growing Awareness on Personalized Medicine
                    5.2.1.4 Increasing Adoption of Point-Of-Care Testing
           5.2.2 Restraint
                    5.2.2.1 Unfavorable Reimbursement Scenario
           5.2.3 Opportunities
                    5.2.3.1 Development of Condition-Specific Markers and Tests
                    5.2.3.2 Growing Significance of Companion Diagnostics
                    5.2.3.3 Growth Opportunities in Emerging Countries
           5.2.4 Challenges
                    5.2.4.1 Changing Regulatory Landscape
                    5.2.4.2 Operational Barriers Faced in Conducting Diagnostic Tests

6 Industry Insights
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Automation of Clinical Laboratory Techniques
           6.2.2 Microfluidics-Based Poc and Loc Diagnostic Devices for Laboratory Testing
           6.2.3 Rise in Number of Reagent Rental Agreements
    6.3 Regulatory Overview
           6.3.1 US
           6.3.2 Canada
           6.3.3 Europe
           6.3.4 Japan
           6.3.5 China
           6.3.6 India
           6.3.7 Indonesia
           6.3.8 Russia
           6.3.9 Saudi Arabia
           6.3.10 Mexico
           6.3.11 Brazil
           6.3.12 South Korea
    6.4 Vendor Benchmarking

7 In Vitro Diagnostics Market, By Product & Service
    7.1 Introduction
    7.2 Reagents & Kits
    7.3 Instruments
           7.3.1 Fully Automated Instruments
           7.3.2 Semi-Automated Instruments
           7.3.3 Other Instruments
    7.4 Data Management Software
    7.5 Services

8 In Vitro Diagnostics Market, By Technology
    8.1 Introduction
    8.2 Immunoassay/Immunochemistry
           8.2.1 Enzyme-Linked Immunosorbent Assay
                    8.2.1.1 Chemiluminescence Immunoassays
                    8.2.1.2 Fluorescence Immunoassays
                    8.2.1.3 Colorimetric Immunoassays
           8.2.2 Radioimmunoassay
           8.2.3 Rapid Test
           8.2.4 Western Blotting
           8.2.5 Enzyme-Linked Immunospot Assays
    8.3 Clinical Chemistry
           8.3.1 Basic Metabolic Panel
           8.3.2 Electrolyte Panel
           8.3.3 Liver Panel
           8.3.4 Lipid Profile
           8.3.5 Renal Profile
           8.3.6 Thyroid Function Panel
           8.3.7 Specialty Chemical Tests
    8.4 Molecular Diagnostics
           8.4.1 Polymerase Chain Reaction
           8.4.2 Isothermal Nucleic Acid Amplification Technology
           8.4.3 Microarray
           8.4.4 Hybridization
           8.4.5 Dna Sequencing & Next-Generation Sequencing
           8.4.6 Other Mdx Technologies
    8.5 Microbiology
    8.6 Hematology
    8.7 Coagulation and Hemostasis
    8.8 Urinalysis
    8.9 Other IVD Technologies

9 In Vitro Diagnostics Market, By Application
    9.1 Introduction
    9.2 Infectious Diseases
    9.3 Diabetes
    9.4 Oncology
    9.5 Cardiology
    9.6 Autoimmune Diseases
    9.7 Nephrology
    9.8 Drug Testing/Pharmacogenomics
    9.9 HIV/Aids
    9.10 Other Applications

10 In Vitro Diagnostics Market, By End User
     10.1 Introduction
     10.2 Hospitals
     10.3 Laboratories
             10.3.1 Large/Reference Laboratories
             10.3.2 Medium-Sized Laboratories
             10.3.3 Small Laboratories
     10.4 Point-Of-Care Testing
     10.5 Patient Self-Testing
     10.6 Academic Institutes
     10.7 Other End Users

11 In Vitro Diagnostics Market, By Region
     11.1 Introduction
     11.2 North America
             11.2.1 US
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 UK
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Russia
             11.3.7 Rest of Europe
     11.4 Asia Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 South Korea
             11.4.5 Indonesia
             11.4.6 Australia
             11.4.7 Singapore
             11.4.8 Rest of Asia Pacific
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America
     11.6 Middle East & Africa
             11.6.1 Saudi Arabia
             11.6.2 Rest of the Middle East & Africa

12 Competitive Landscape
     12.1 Introduction
     12.2 Market Share Analysis
             12.2.1 Market Share Analysis, By Technology
                        12.2.1.1 Clinical Chemistry
                        12.2.1.2 Immunochemistry/Immunoassay
                        12.2.1.3 Microbiology
                        12.2.1.4 Molecular Diagnostics
                        12.2.1.5 Hematology
                        12.2.1.6 Coagulation
     12.3 Competitive Situation and Trends
             12.3.1 Product Launches
             12.3.2 Agreements, Partnerships, and Collaborations
             12.3.3 Acquisitions
             12.3.4 Expansions
             12.3.5 Other Strategies

13 Company Profiles
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
     13.1 Roche Diagnostics
     13.2 Danaher Corporation
     13.3 Abbott Laboratories, Inc.
     13.4 Siemens AG
     13.5 Sysmex Corporation
     13.6 Thermo Fisher Scientific
     13.7 Becton, Dickinson and Company
     13.8 Biomιrieux Sa
     13.9 Bio-Rad Laboratories, Inc.
     13.10 Johnson & Johnson
     13.11 Agilent Technologies
     13.12 Qiagen
     13.13 Diasorin
     13.14 Leica Biosystems Nussloch GmbH
     13.15 Cepheid
     13.16 Quidel Corporation
     13.17 Orasure Technologies, Inc.
     13.18 Stago
     13.19 Hologic, Inc.
     13.20 Ortho Clinical Diagnostics (A Part of Carlyle Group)

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Ntroducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports
     14.7 Author Details


List of Tables (295 Tables)

Table 1 Global IVD Market Snapshot
Table 2 Number of People With Diabetes, By Region, 2015 vs 2040 (Million Individuals)
Table 3 Fully Automated Systems Launched By Key Players
Table 4 New Tests Launched By Key Players
Table 5 US: Classification of In Vitro Diagnostic Devices
Table 6 US: Time, Cost, and Complexity of Registration Process
Table 7 Canada: Time, Cost, and Complexity of Registration Process
Table 8 Europe: Classification of IVD Devices
Table 9 Europe: Time, Cost, and Complexity of Registration Process
Table 10 Japan: Classification of IVD Reagents
Table 11 Japan: Time, Cost, and Complexity of Registration Process
Table 12 China: Time, Cost, and Complexity of Registration Process
Table 13 India: Time, Cost, and Complexity of Registration Process
Table 14 Indonesia: Registration Process for IVD Devices
Table 15 Russia: Classification of IVD Devices
Table 16 Saudi Arabia: Time, Cost, and Complexity of Registration Process
Table 17 Mexico: Time, Cost, and Complexity of Registration Process
Table 18 Brazil: Time, Cost, and Complexity of Registration Process
Table 19 South Korea: Time, Cost, and Complexity of Registration Process
Table 20 In Vitro Diagnostic Products & Services Market: Product Portfolio Analysis
Table 21 IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 22 In Vitro Diagnostic Reagents & Kits Market, By Country, 2016–2023 (USD Million)
Table 23 In Vitro Diagnostic Reagents & Kits Market, By Technology, 2016–2023 (USD Million)
Table 24 In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 25 In Vitro Diagnostic Instruments Market, By Country, 2016–2023 (USD Million)
Table 26 In Vitro Diagnostic Instruments Market, By Technology, 2016–2023 (USD Million)
Table 27 Major Lab Automation Systems & Fully Automated Instruments in the Market
Table 28 Fully Automated IVD Instruments Market, By Country, 2016–2023 (USD Million)
Table 29 Semi-Automated IVD Instruments Market, By Country, 2016–2023 (USD Million)
Table 30 Other IVD Instruments Market, By Country, 2016–2023 (USD Million)
Table 31 Key Data Management Software Solutions Available in the Market
Table 32 In Vitro Diagnostic Data Management Software Market, By Country, 2016–2023 (USD Million)
Table 33 In Vitro Diagnostic Data Management Software Market, By Technology, 2016–2023 (USD Million)
Table 34 In Vitro Diagnostic Services Market, By Country, 2016–2023 (USD Million)
Table 35 In Vitro Diagnostic Services Market, By Technology, 2016–2023 (USD Million)
Table 36 In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 37 Immunoassay/Immunochemistry Analyzers Available in the Market
Table 38 Immunoassay/Immunochemistry Market, By Type, 2016–2023 (USD Million)
Table 39 Immunoassay/Immunochemistry Market, By Country, 2016–2023 (USD Million)
Table 40 Elisa Analyzers Available in the Market
Table 41 Enzyme-Linked Immunosorbent Assay Market, By Country, 2016–2023 (USD Million)
Table 42 Enzyme-Linked Immunosorbent Assay Market, By Type, 2016–2023 (USD Million)
Table 43 Chemiluminescence Immunoassay Systems Available in the Market
Table 44 Chemiluminescence Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 45 Fluorescence Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 46 Colorimetric Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 47 Radioimmunoassay Market, By Country, 2016–2023 (USD Million)
Table 48 Rapid Tests Available in the Market
Table 49 Rapid Test Market, By Country, 2016–2023 (USD Million)
Table 50 Western Blotting Systems Available in the Market
Table 51 Western Blotting Market, By Country, 2016–2023 (USD Million)
Table 52 Elispot Assays Market, By Country, 2016–2023 (USD Million)
Table 53 Clinical Chemistry Analyzers for High- and Mid-Volume Laboratories
Table 54 Clinical Chemistry Analyzers for Low-Volume Laboratories
Table 55 Blood Gas Analyzers Available in the Market
Table 56 Clinical Chemistry Market, By Country, 2016–2023 (USD Million)
Table 57 Clinical Chemistry Market, By Test Type, 2016–2023 (USD Million)
Table 58 Basic Metabolic Panel Market, By Country, 2016–2023 (USD Million)
Table 59 Electrolyte Panel Market, By Country, 2016–2023 (USD Million)
Table 60 Liver Panel Market, By Country, 2016–2023 (USD Million)
Table 61 Lipid Profile Market, By Country, 2016–2023 (USD Million)
Table 62 Renal Profile Market, By Country, 2016–2023 (USD Million)
Table 63 Thyroid Function Panel Market, By Country, 2016–2023 (USD Million)
Table 64 Specialty Chemical Tests Market, By Country, 2016–2023 (USD Million)
Table 65 Automated Molecular Platforms, By Key Market Player
Table 66 Molecular Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 67 Molecular Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 68 PCR Instruments, By Key Market Player
Table 69 PCR Market, By Country, 2016–2023 (USD Million)
Table 70 Isothermal Nucleic Acid Amplification Technology Market, By Country, 2016–2023 (USD Million)
Table 71 Microarray Market, By Country, 2016–2023 (USD Million)
Table 72 Hybridization Market, By Country, 2016–2023 (USD Million)
Table 73 Ngs Instruments, By Key Market Player
Table 74 Dna Sequencing & Ngs Market, By Country, 2016–2023 (USD Million)
Table 75 Other Molecular Diagnostic Technologies Market, By Country, 2016–2023 (USD Million)
Table 76 Microbiology Instruments, By Key Market Player
Table 77 Microbiology Market, By Country, 2016–2023 (USD Million)
Table 78 Hematology Analyzers, By Key Market Player
Table 79 Hematology Market, By Country, 2016–2023 (USD Million)
Table 80 Coagulation Analyzers, By Key Market Player
Table 81 Point of Care/Self-Monitoring Coagulation Analyzers, By Key Market Player
Table 82 Coagulation & Hemostasis Market, By Country, 2016–2023 (USD Million)
Table 83 Urinalysis Instruments, By Key Market Player
Table 84 Urinalysis Market, By Country, 2016–2023 (USD Million)
Table 85 Blood Glucose Testing Systems, By Key Market Player
Table 86 Tissue Processors, Embedders, Microtomes, and Stainers Offered By Key Market Players
Table 87 Other IVD Technologies Market, By Country, 2016–2023 (USD Million)
Table 88 In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 89 IVD Market for Infectious Diseases, By Country, 2016–2023 (USD Million)
Table 90 Global Diabetic Patient Population in 2015 and 2040 (Million)
Table 91 In Vitro Diagnostic Market for Diabetes, By Country, 2016–2023 (USD Million)
Table 92 In Vitro Diagnostic Market for Oncology, By Country, 2016–2023 (USD Million)
Table 93 Market for Cardiology, By Country, 2016–2023 (USD Million)
Table 94 In Vitro Diagnostic Market for Autoimmune Diseases, By Country, 2016–2023 (USD Million)
Table 95 Market for Nephrology, By Country, 2016–2023 (USD Million)
Table 96 In Vitro Diagnostic Market for Drug Testing/Pharmacogenomics, By Country, 2016–2023 (USD Million)
Table 97 IVD Market for HIV/Aids, By Country, 2016–2023 (USD Million)
Table 98 In Vitro Diagnostics Market for Other Applications, By Country, 2016–2023 (USD Million)
Table 99 Market, By End User, 2016–2023 (USD Million)
Table 100 IVD Market for Hospitals, By Country, 2016–2023 (USD Million)
Table 101 In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 102 Market for Laboratories, By Country, 2016–2023 (USD Million)
Table 103 Large/Reference Laboratories Market, By Country, 2016–2023 (USD Million)
Table 104 Medium-Sized Laboratories Market, By Country, 2016–2023 (USD Million)
Table 105 Small Laboratories Market, By Country, 2016–2023 (USD Million)
Table 106 In Vitro Diagnostics Market for Poc Testing, By Country, 2016–2023 (USD Million)
Table 107 IVD Market for Patient Self-Testing, By Country, 2016–2023 (USD Million)
Table 108 In Vitro Diagnostic Market for Academic Institutes, By Country, 2016–2023 (USD Million)
Table 109 In Vitro Diagnostic In Vitro Diagnostics Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 110 Market, By Region, 2016–2023 (USD Million)
Table 111 North America: In Vitro Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 112 North America: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 113 North America: Instruments Market, By Type, 2016–2023 (USD Million)
Table 114 North America: Market, By Technology, 2016–2023 (USD Million)
Table 115 North America: Market, By Application, 2016–2023 (USD Million)
Table 116 North America: IVD Market, By End User, 2016–2023 (USD Million)
Table 117 North America: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 118 US: Key Macroindicators
Table 119 US: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 120 US: Instruments Market, By Type, 2016–2023 (USD Million)
Table 121 US: In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 122 US: IVD Market, By Application, 2016–2023 (USD Million)
Table 123 US: IVD Market, By End User, 2016–2023 (USD Million)
Table 124 US: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 125 Canada: Key Macroindicators
Table 126 Canada: In Vitro Diagnostic Market, By Product & Service, 2016–2023 (USD Million)
Table 127 Canada: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 128 Canada: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 129 Canada: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 130 Canada: IVD Market, By End User, 2016–2023 (USD Million)
Table 131 Canada: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 132 Europe: Market, By Country/Region, 2016–2023 (USD Million)
Table 133 Europe: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 134 Europe: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 135 Europe: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 136 Europe: IVD Market, By Application, 2016–2023 (USD Million)
Table 137 Europe: In Vitro Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 138 Europe: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 139 Germany: Key Macroindicators
Table 140 Germany: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 141 Germany: Instruments Market, By Type, 2016–2023 (USD Million)
Table 142 Germany: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 143 Germany: IVD Market, By Application, 2016–2023 (USD Million)
Table 144 Germany: IVD Market, By End User, 2016–2023 (USD Million)
Table 145 Germany: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 146 France: Key Macroindicators
Table 147 France: Market, By Product & Service, 2016–2023 (USD Million)
Table 148 France: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 149 France: IVD Market, By Technology, 2016–2023 (USD Million)
Table 150 France: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 151 France: Market, By End User, 2016–2023 (USD Million)
Table 152 France: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 153 UK: Key Macroindicators
Table 154 UK: Market, By Product & Service, 2016–2023 (USD Million)
Table 155 UK: Instruments Market, By Type, 2016–2023 (USD Million)
Table 156 UK: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 157 UK: Market, By Application, 2016–2023 (USD Million)
Table 158 UK: Market, By End User, 2016–2023 (USD Million)
Table 159 UK: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 160 Italy: Key Macroindicators
Table 161 Italy: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 162 Italy: Instruments Market, By Type, 2016–2023 (USD Million)
Table 163 Italy: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 164 Italy: IVD Market, By Application, 2016–2023 (USD Million)
Table 165 Italy: Market, By End User, 2016–2023 (USD Million)
Table 166 Italy: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 167 Spain: Key Macroindicators
Table 168 Spain: Market, By Product & Service, 2016–2023 (USD Million)
Table 169 Spain: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 170 Spain: IVD Market, By Technology, 2016–2023 (USD Million)
Table 171 Spain: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 172 Spain: IVD Market, By End User, 2016–2023 (USD Million)
Table 173 Spain: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 174 Russia: Key Macroindicators
Table 175 Russia: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 176 Russia: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 177 Russia: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 178 Russia: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 179 Russia: Market, By End User, 2016–2023 (USD Million)
Table 180 Russia: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 181 RoE: Market, By Product & Service, 2016–2023 (USD Million)
Table 182 RoE: Instruments Market, By Type, 2016–2023 (USD Million)
Table 183 RoE: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 184 RoE: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 185 RoE: IVD Market, By End User, 2016–2023 (USD Million)
Table 186 RoE: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 187 Asia Pacific: Market, By Country/Region, 2016–2023 (USD Million)
Table 188 Asia Pacific: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 189 Asia Pacific: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 190 Asia Pacific: IVD Market, By Technology, 2016–2023 (USD Million)
Table 191 Asia Pacific: IVD Market, By Application, 2016–2023 (USD Million)
Table 192 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 193 Asia Pacific: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 194 Japan: Key Macroindicators
Table 195 Japan: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 196 Japan: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 197 Japan: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 198 Japan: In Vitro Diagnostic Market, By Application, 2016–2023 (USD Million)
Table 199 Japan: IVD Market, By End User, 2016–2023 (USD Million)
Table 200 Japan: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 201 China: Key Macroindicators
Table 202 China: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 203 China: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 204 China: IVD Market, By Technology, 2016–2023 (USD Million)
Table 205 China: Market, By Application, 2016–2023 (USD Million)
Table 206 China: IVD Market, By End User, 2016–2023 (USD Million)
Table 207 China: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 208 India: Key Macroindicators
Table 209 India: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 210 India: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 211 India: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 212 India: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 213 India: Market, By End User, 2016–2023 (USD Million)
Table 214 India: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 215 South Korea: Market, By Product & Service, 2016–2023 (USD Million)
Table 216 South Korea: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 217 South Korea: Market, By Technology, 2016–2023 (USD Million)
Table 218 South Korea: Market, By Application, 2016–2023 (USD Million)
Table 219 South Korea: IVD Market, By End User, 2016–2023 (USD Million)
Table 220 South Korea: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 221 Indonesia: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 222 Indonesia: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 223 Indonesia: Market, By Technology, 2016–2023 (USD Million)
Table 224 Indonesia: IVD Market, By Application, 2016–2023 (USD Million)
Table 225 Indonesia: IVD Market, By End User, 2016–2023 (USD Million)
Table 226 Indonesia: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 227 Australia: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million) 
Table 228 Australia: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million) 
Table 229 Australia: In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million) 
Table 230 Australia: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million) 
Table 231 Australia: In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million) 
Table 232 Australia: In Vitro Diagnostics Market For Laboratories, By Size, 2016–2023 (USD Million)
Table 233 Singapore: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million) 
Table 234 Singapore: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million) 
Table 235 Singapore: In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million) 
Table 236 Singapore: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million) 
Table 237 Singapore: In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million) 
Table 238 Singapore: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 239 RoAPAC: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 240 RoAPAC: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 241 RoAPAC: Market, By Technology, 2016–2023 (USD Million)
Table 242 RoAPAC: Market, By Application, 2016–2023 (USD Million)
Table 243 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 244 RoAPAC: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 245 Latin America: In Vitro Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 246 Latin America: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 247 Latin America: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 248 Latin America: Market, By Technology, 2016–2023 (USD Million)
Table 249 Latin America: Market, By Application, 2016–2023 (USD Million)
Table 250 Latin America: In Vitro Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 251 Latin America: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 252 Brazil: Key Macroindicators
Table 253 Brazil: Market, By Product & Service, 2016–2023 (USD Million)
Table 254 Brazil: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 255 Brazil: IVD Market, By Technology, 2016–2023 (USD Million)
Table 256 Brazil: IVD Market, By Application, 2016–2023 (USD Million)
Table 257 Brazil: In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 258 Brazil: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 259 Mexico: Key Macroindicators
Table 260 Mexico: Market, By Product & Service, 2016–2023 (USD Million)
Table 261 Mexico: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 262 Mexico: Market, By Technology, 2016–2023 (USD Million)
Table 263 Mexico: Market, By Application, 2016–2023 (USD Million)
Table 264 Mexico: IVD Market, By End User, 2016–2023 (USD Million)
Table 265 Mexico: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 266 RoLA: Market, By Product & Service, 2016–2023 (USD Million)
Table 267 RoLA: Instruments Market, By Type, 2016–2023 (USD Million)
Table 268 RoLA: Market, By Technology, 2016–2023 (USD Million)
Table 269 RoLA: Market, By Application, 2016–2023 (USD Million)
Table 270 RoLA: IVD Market, By End User, 2016–2023 (USD Million)
Table 271 RoLA: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 272 Middle East and Africa: Market, By Country, 2016–2023 (USD Million)
Table 273 Middle East and Africa: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 274 Middle East and Africa: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 275 Middle East and Africa: Market, By Technology, 2016–2023 (USD Million)
Table 276 Middle East and Africa: Market, By Application, 2016–2023 (USD Million)
Table 277 Middle East and Africa: Market, By End User, 2016–2023 (USD Million)
Table 278 Middle East and Africa: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 279 Saudi Arabia: Market, By Product & Service, 2016–2023 (USD Million)
Table 280 Saudi Arabia: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 281 Saudi Arabia: In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 282 Saudi Arabia: Market, By Application, 2016–2023 (USD Million)
Table 283 Saudi Arabia: Market, By End User, 2016–2023 (USD Million)
Table 284 Saudi Arabia: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 285 Rest of Middle East and Africa: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 286 Rest of Middle East and Africa: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 287 Rest of Middle East and Africa: Market, By Technology, 2016–2023 (USD Million)
Table 288 Rest of Middle East and Africa: In Vitro Diagnostic Market, By Application, 2016–2023 (USD Million)
Table 289 Rest of Middle East and Africa: In Vitro Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 290 Rest of Middle East and Africa: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 291 Product Launches, 2014–2018
Table 292 Agreements, Partnerships, and Collaborations, 2014–2017
Table 293 Acquisitions, 2014–2017
Table 294 Expansions, 2015–2017
Table 295 Other Strategies, 2014–2017


List of Figures (63 Figures)

Figure 1 In Vitro Diagnostics Market Segmentation
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 IVD Market, By Product & Service, 2018 vs 2023 (USD Billion)
Figure 7 IVD Market, By Application, 2018 vs 2023 (USD Billion)
Figure 8 IVD Market, By Technology, 2018 vs 2023 (USD Billion)
Figure 9 Immunochemistry/ Immunoassay Market, By Type, 2018 vs 2023 (USD Billion)
Figure 10 Clinical Chemistry Market, By Type, 2018 vs 2023 (USD Billion)
Figure 11 Molecular Diagnostics Market, By Type, 2018 vs 2023 (USD Billion)
Figure 12 IVD Market, By End User, 2018 vs 2023 (USD Billion)
Figure 13 Geographic Snapshot of the In Vitro Diagnostics Market
Figure 14 Rising Incidence of Chronic Lifestyle Diseases is Driving the Growth of the IVD Market
Figure 15 Reagents & Kits Commanded the Largest Share in 2017
Figure 16 The US Accounted for the Largest Share of the IVD Market in 2017
Figure 17 APAC to Grow at the Highest CAGR in the Forecast Period
Figure 18 Developing Markets to Register A Higher Growth During the Forecast Period
Figure 19 In Vitro Diagnostics Market: Drivers, Restraints, Opportunities, & Challenges
Figure 20 Increase in Geriatric Population, By Country (2011–2030)
Figure 21 Increase in Gross Expenditure on R&D in Emerging Countries, 2012–2014
Figure 22 US: Regulatory Process for IVD Devices
Figure 23 Canada: Regulatory Process for IVD Devices in Canada
Figure 24 Europe: Regulatory Process for IVD Devices
Figure 25 Regulatory Process for IVD Devices in Japan
Figure 26 India: Regulatory Process for IVD Devices
Figure 27 Mexico: Regulatory Process for IVD Devices
Figure 28 Brazil: Regulatory Process for IVD Devices
Figure 29 Reagents & Kits Segment to Witness the Highest Growth Rate During the Forecast Period
Figure 30 Molecular Diagnostics Segment to Register the Highest CAGR During the Forecast Period (2018–2023)
Figure 31 Rapid Tests Segment to Register the Highest Growth Rate During the Forecast Period (2018–2023)
Figure 32 Oncology, the Fastest-Growing Application Segment of the IVD Market
Figure 33 Number of People Living With HIV Globally, 2010–2015
Figure 34 In Vitro Diagnostics Market, By End User, 2018 vs 2023 (USD Million)
Figure 35 Number of Hospitals, By Country/Region (2015)
Figure 36 Number of Laboratories, By Country/Region (2015)
Figure 37 Healthcare Expenditure Across Major Countries, 2000 vs 2014
Figure 38 North America to Account for the Largest Share of the IVD Market in 2023
Figure 39 Geographical Snapshot of the Global IVD Market
Figure 40 North America: Market Snapshot
Figure 41 Europe: IVD Market Snapshot
Figure 42 Asia Pacific: IVD Market Snapshot
Figure 43 Key Developments in the In Vitro Diagnostic Market From 2014 to 2018
Figure 44 Global IVD Market Share Analysis, By Key Player, 2017
Figure 45 Global Clinical Chemistry Market Share Analysis, By Key Players (2017)
Figure 46 Global Immunoassays Market Share Analysis, By Key Players (2017)
Figure 47 Global Microbiology Market Share Analysis, By Key Players (2017)
Figure 48 Global Molecular Diagnostics Market Share Analysis, By Key Players (2017)
Figure 49 Global Hematology Market Share Analysis, By Key Players (2017)
Figure 50 Global Clinical Coagulation Analyzers Market Share Analysis, By Key Players (2017)
Figure 51 F. Hoffmann-La Roche.: Company Snapshot (2016)
Figure 52 Danaher Corporation: Company Snapshot (2016)
Figure 53 Abbott Laboratories: Company Snapshot (2016)
Figure 54 Siemens AG: Company Snapshot (2017)
Figure 55 Sysmex Corporation: Company Snapshot (2017)
Figure 56 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 57 Becton, Dickinson and Company: Company Snapshot (2017)
Figure 58 Biomιrieux Sa: Company Snapshot (2016)
Figure 59 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 60 Johnson & Johnson: Company Snapshot (2016)
Figure 61 Agilent Technologies: Company Snapshot (2016)
Figure 62 Qiagen: Company Snapshot (2016)
Figure 63 Diasorin: Company Snapshot (2016)

This study involved four major activities in estimating the current size of the in-vitro diagnostics market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the sizes of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; trade directories; and databases such as D&B Hoovers and Bloomberg Businessweek were referred to identify and collect information for this study.

Primary Research

The IVD market comprises several stakeholders such as IVD instrument manufacturers, IVD reagent manufacturers, suppliers and distributors of IVD products, group purchase organizations (GPOs), OEM manufacturers, pathologists and pathology laboratories, healthcare services providers (hospitals and clinics),  healthcare institutions, research institutions, and government associations. Primary sources from the supply side, including CEOs, managing director, vice presidents, marketing and sales directors, business development managers, technology and innovation directors of IVD product companies, suppliers, and distributors, have been considered. Demand-side primary sources include industry experts such as directors of hospitals and clinics, reference laboratory managers, managers at blood centers, research scientists, and related key opinion leaders.

In Vitro Diagnostics/ IVD Market: Breakdown of Primary Interviews

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the in-vitro diagnostics market. These methods were also used to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s market size, in terms of value, has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size-using market size estimation processes as explained above-the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Objectives of the Study

  • To define, describe, and forecast the global in vitro diagnostics market on the basis of product & service, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the IVD market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the global IVD market with respect to five main regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically profile the key players in the global IVD market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, expansions, product/technology developments, and product upgrades in the IVD market

1. Micromarkets are segments and subsegments of the in-vitro diagnostics (IVD) market included in the report.

2. Core competencies of the companies are captured in terms of their product portfolio, key developments, and strategies adopted to sustain their positions in the market.

Scope of the Report

Report Metric

Details

Market size available for years

2016-2023

Base year considered

2017

Forecast period

2018-2023

Forecast units

Value (USD Million)

Segments covered

Product & Service, Technology, Application, End User, & Region

Geographies covered

North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

F. Hoffmann-La Roche Ltd. (Roche Diagnostics) (Switzerland), Danaher Corporation (US), Abbott Laboratories, Inc. (US), Siemens AG (Germany), Sysmex Corporation (Japan), Thermo Fisher Scientific (US), Becton, Dickinson and Company (BD) (US), bioMιrieux SA (France), Bio-Rad Laboratories, Inc. (US), Johnson & Johnson (US), Agilent Technologies (US), Qiagen N.V. (Netherlands), DiaSorin (Italy), Ortho Clinical Diagnostics (US)

This research report categorizes the in-vitro diagnostics (IVD) market into the following segments and subsegments:

In-vitro Diagnostics (IVD) Market, by Product & Service

  • Reagents and Kits
  • Instruments
    • Fully Automated Instruments
    • Semi-automated Instruments
    • Other Instruments
  • Data Management Systems/Software
  • Services

    In-vitro Diagnostics (IVD) Market, by Technology

    • Clinical Chemistry
    • Immunochemistry/Immunoassays
    • Hematology
    • Coagulation & Hemostasis
    • Microbiology
    • Molecular Diagnostics
    • Urinalysis
    • Other Technologies

    In-vitro Diagnostics (IVD) Market, by Application

    • Diabetes
    • Infectious Diseases
    • Oncology
    • Cardiology
    • Nephrology
    • Autoimmune Diseases
    • Drug Testing/Pharmacogenomics
    • HIV/AIDS
    • Other Applications

    In-vitro Diagnostics (IVD) Market, by End User

    • Hospitals
    • Laboratories
      • Large/Reference Laboratories
      • Medium-sized Laboratories
      • Small Laboratories
    • Point-of-care Testing
    • Patient Self-testing
    • Academic Institutes
    • Other End Users

    In-vitro Diagnostics Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • Rest of the Middle East and Africa

    Available customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of each company

    Geographic Analysis

    • Further breakdown of the Rest of Asia Pacific in vitro diagnostics (IVD) market into Thailand, Australia, New Zealand, and others
    • Further breakdown of the Latin American in vitro diagnostics (IVD) market into Colombia, Argentina, and Rest of Latin America
    • Further breakdown of the Middle Eastern & African in vitro diagnostics (IVD) market into United Arab Emirates, South Africa, Egypt, and Rest of the Middle East & Africa

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)
  • Report Code
    MD 3609
    Published ON
    Mar, 2018
    Choose License Type
    BUY NOW
    • SHARE
    X
    Request Customization
    Speak to Analyst
    Speak to Analyst
    OR FACE-TO-FACE MEETING
    PERSONALIZE THIS RESEARCH
    • Triangulate with your Own Data
    • Get Data as per your Format and Definition
    • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
    • Any level of Personalization
    REQUEST A FREE CUSTOMIZATION
    LET US HELP YOU!
    • What are the Known and Unknown Adjacencies Impacting the In Vitro Diagnostics Market
    • What will your New Revenue Sources be?
    • Who will be your Top Customer; what will make them switch?
    • Defend your Market Share or Win Competitors
    • Get a Scorecard for Target Partners
    CUSTOMIZED WORKSHOP REQUEST
    ADJACENT MARKETS
    REQUEST BUNDLE REPORTS
    +1-888-600-6441
    • Call Us
    • +1-888-600-6441 (Corporate office hours)
    • +1-888-600-6441 (US/Can toll free)
    • +44-800-368-9399 (UK office hours)
    CONNECT WITH US
    ABOUT TRUST ONLINE
    © MarketsandMarkets Research Private Ltd. All rights reserved
    ...

    Digital Virtual Assistant - MarketsandMarkets

    Home